GLP-1 Drugs and Bowel Obstruction Risk: Evaluating a Safety Signal
Analysis of bowel obstruction and ileus events in GLP-1 drug users evaluates this safety signal using clinical data and pharmacovigilance reports.
Quick Facts
What This Study Found
Analysis of bowel obstruction and ileus events in GLP-1 drug users evaluates this safety signal using clinical data and pharmacovigilance reports.
Key Numbers
317 records screened. Meta-analysis included RCTs and observational studies. No statistically significant increase in bowel obstruction or ileus found.
How They Did This
Study design and methodology detailed in the full publication.
Why This Research Matters
These findings are relevant to the growing population of patients using or considering peptide-based therapies.
The Bigger Picture
This study contributes to the expanding evidence for peptide-based therapeutics in clinical medicine.
What This Study Doesn't Tell Us
Study limitations discussed in the full publication.
Questions This Raises
- ?What are the long-term implications?
- ?How do results compare to existing evidence?
- ?What further research is needed?
Trust & Context
- Key Stat:
- Key finding Analysis of bowel obstruction and ileus events in GLP-1 drug users evaluates this safety signal usin
- Evidence Grade:
- Evidence assessment based on study design in publication.
- Study Age:
- Published in 2025.
- Original Title:
- Evaluating bowel obstruction and ileus events in patients on GLP-1 receptor agonists: a systematic review and meta-analysis.
- Published In:
- Expert opinion on drug safety, 1-9 (2025)
- Database ID:
- RPEP-09855
Evidence Hierarchy
Combines results from multiple studies to find an overall pattern.
What do these levels mean? →Frequently Asked Questions
What does this study mean for patients?
Analysis of bowel obstruction and ileus events in GLP-1 drug users evaluates this safety signal using clinical data and pharmacovigilance reports.
How reliable are these findings?
Consult the full publication and your healthcare provider for personalized guidance.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09855APA
Alfehaid, Lama; Alyami, Majed; Almohareb, Sumaya; Alshaya, Omar; Almutairi, Abdulaali. (2025). Evaluating bowel obstruction and ileus events in patients on GLP-1 receptor agonists: a systematic review and meta-analysis.. Expert opinion on drug safety, 1-9. https://doi.org/10.1080/14740338.2025.2465870
MLA
Alfehaid, Lama, et al. "Evaluating bowel obstruction and ileus events in patients on GLP-1 receptor agonists: a systematic review and meta-analysis.." Expert opinion on drug safety, 2025. https://doi.org/10.1080/14740338.2025.2465870
RethinkPeptides
RethinkPeptides Research Database. "Evaluating bowel obstruction and ileus events in patients on..." RPEP-09855. Retrieved from https://rethinkpeptides.com/research/alfehaid-2025-evaluating-bowel-obstruction-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.